微信关注
Total item
Cart Subtotal
￥ 0.00 Aurora Kinase
| Catalog No. | Inhibitor Name | Aurora A | Aurora B | Aurora C | Other |
|---|---|---|---|---|---|
| A10004 | Alisertib | **** | * | ||
| A10981 | Tozasertib | **** | ** | *** | Bcr-Abl,FLT3 |
| A10109 | Barasertib | * | **** | ||
| A11009 | ZM 447439 | ** | * | LCK,Src,MEK1 | |
| A10601 | MLN8054 | **** | * | LCK,PKA,CK2 | |
| A10715 | Danusertib | *** | ** | ** | Abl,TrkA,RET |
| A10095 | AT9283 | **** | **** | JAK3,JAK2,Abl1 (T315I) | |
| A10494 | JNJ-7706621 | *** | *** | CDK2/CyclinE,CDK2/CyclinA,CDK1/CyclinB | |
| A10448 | Hesperadin | * | TbAUK1 | ||
| A10100 | Aurora A Inhibitor I | **** | * | * | |
| A10508 | KW-2449 | ** | FLT3 (D835Y),Abl (T315I),FLT3 | ||
| A10851 | SNS-314 Mesylate | *** | ** | **** | |
| A10352 | ENMD-2076 | *** | * | FLT3,RET,VEGFR3/FLT4 | |
| A10714 | PHA-680632 | ** | * | * | FGFR1,PLK1,FLT3 |
| A11410 | MK-5108 | **** | |||
| A10248 | CYC116 | *** | *** | VEGFR2,FLT3,CDK2/CyclinE | |
| A11066 | AMG-900 | *** | **** | **** | p38α,TYK2,JNK2 |
| A11171 | PF-03814735 | **** | *** | FLT1,FAK,TrkA | |
| A10184 | CCT129202 | ** | * | * | |
| A11168 | GSK1070916 | * | **** | *** | FLT1,Tie-2,SIK |
| A11067 | TAK-901 | ** | *** | JAK3,c-Src,YES1 | |
| A11081 | CCT137690 | *** | ** | ** | |
| A13396 | MK-8745 | **** | * | ||
| A10352 | ENMD-2076 L-(*)-Tartaric acid | *** | * | FLT3,RET,VEGFR3/FLT4 | |
| A15762 | BI-847325 | ** | **** | *** | |
| A13250 | Reversine | *** | *** | ** | human A3 adenosine receptor |
Notes:
1.Hover mouse over "" to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of "" is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.
22 个项目
每页
-
PF-03814735
Catalog No. A11171 Aurora A/B Kinase 抑制剂PF-03814735是一种新颖，有效且可逆的Aurora A/B抑制剂，IC50为0.8 nM/5 nM，对Flt3，FAK，TrkA的效力较低，对Met和FGFR1的活性最低。 了解更多 -
Danusertib (PHA-739358)
Catalog No. A10715 Aurora 抑制剂Danusertib (PHA-739358)是Aurora A/B/C的Aurora激酶抑制剂，在无细胞分析中的IC50为13 nM/79nM/61 nM，对Abl，TrkA，c-RET和FGFR1以及更低的浓度具有中等效力 对Lck，VEGFR2/3，c-Kit，CDK2等有效。 了解更多 -
AZD1152-HQPA (Barasertib)
Catalog No. A10109 Aurora Kinase B 抑制剂AZD1152-HQPA (Barasertib)是Aurora B的高效抑制剂，Ki值分别为0.36（Aurora B）和1369 nM（Aurora A），与一组其他50种激酶相比具有很高的特异性。 了解更多 -
PHA-680632
Catalog No. A10714 Aurora 抑制剂PHA-680632是Aurora A，Aurora B和Aurora C的有效抑制剂，IC50分别为27 nM，135 nM和120 nM。对于FGFR1，FLT3，LCK，PLK1，STLK2和VEGFR2/3，它的IC50高10到200倍。 了解更多 -
Hesperadin
Catalog No. A10448 Aurora B Kinase 抑制剂Hesperadin是一种人极光B抑制剂，IC50为40 nM，用于防止底物磷酸化。它显著降低AMPK、Lck、MKK1、MAPKAP-K1、CHK1和PHK的活性，而不抑制MKK1在体内的活性。 了解更多 -
JNJ-7706621
Catalog No. A10494 CDK/Aurora A/B 抑制剂JNJ-7706621是对CDK1/2具有最高效力的pan-CDK抑制剂，IC50为9 nM/4 nM，并且在无细胞分析中对CDK1/2的选择性是CDK3/4/6的6倍以上。它还能有效抑制极光A/B，对Plk1和Wee1没有活性。 了解更多 -
GSK1070916
Catalog No. A11168 Aurora Kinase B/C 抑制剂GSK1070916是一种有效的Aurora B/C激酶抑制剂（IC50为3.5 nM/6.5 nM），在组织培养细胞和人肿瘤异种移植模型中具有广泛的抗肿瘤活性。 了解更多 -
CYC116 (CYC-116)
Catalog No. A10248 Aurora Kinase 抑制剂CYC116 (CYC-116)是一种有效的Aurora A/B抑制剂，Ki为8.0 nM/9.2 nM，对VEGFR2(Ki为44 nM)作用稍弱。 了解更多 -
VX-680 (MK-0457, Tozasertib)
Catalog No. A10981 Aurora Kinase 抑制剂VX-680 (MK-0457,Tozasertib)是一种有效的选择性Aurora激酶小分子抑制剂。 了解更多 -
SCH-1473759
Catalog No. A14059
22 个项目
每页
FILTER BY:
ADOOQ 产品质量保证
We promise all products to perform as described.